News Hub | News Direct

All Industries


Article thumbnail News Release

American Drone Dominance: 4 UAS Stocks Poised To Reap Big From Trump’s Executive Orders

ZENA RCAT DPRO UMAC

On June 6, President Donald Trump signed executive orders aimed at bolstering the nation’s drone defense capabilities and aviation innovation, fueling unmanned aerial systems (UAS) or drone stocks' momentum. Highlights of the executive orders included the expanded use of drones beyond visual line of sight (BVLOS) by removing key regulatory hurdles that had restricted the use of drones beyond the operator’s line of sight. For a long time, that restriction had been a barrier to drone deployments in commercial and security operations. The executive orders further mandated a reduction in the country’s reliance on Chinese drone technology by requiring a gradual phase-out of Chinese drones and components across all US government agencies following national security concerns. Going forward, federal agencies would be expected to shift procurement toward domestically produced drone systems as the country secures its supply chains and seeks to grow the US drone economy. Furthermore, the orders tackled the growing challenge of unauthorized and potentially dangerous drones, aiming to protect critical infrastructure, public events, and sensitive government sites. A new task force will be created to oversee and improve counter-UAS strategies, ensuring coordinated efforts across federal, state, and local agencies. With these new executive orders in place, America’s race to become the dominant player in the drone industry just got a major boost, which bodes well for a number of domestic UAS developers. For instance, ZenaTech (NASDAQ:ZENA) announced that its subsidiary ZenaDrone was going to file a patent and accelerate the deployment of Counter-UAS technology to be mounted on the company’s flagship ZenaDrone 1000 drone platform. By leveraging AI and machine learning, ZenaTech aims to establish itself as a key domestic player that offers continuous, autonomous verification of drones, both on-premise and in global airspace, to mitigate drone threats. For context, Counter-UAS technology is used to detect drones in specific airspaces and possesses the capability to track their path as well as the location of the pilot, providing airspace situational awareness to the operator. When the Counter-UAS system identifies a drone signature, it will allow the operator to designate it either as friendly or enemy while leaving authorized drones to continue functioning without interruption. The addressable market for this technology is substantial. According to research from Precedence Research, the global Counter-UAS market size is estimated at $2.97 billion in 2025 and is expected to be worth around $26.26 billion by 2034, accelerating at a CAGR of 27.52% over the period. Zena Drone's counter-UAS technology was originally designed last year but was placed on hold as the company prioritized other commercial and defense applications. However, the recent policy directive on Counter-UAS contained in the White House Executive Order has clarified the urgency and importance of bringing effective drone defense solutions to market. In response, ZenaDrone is accelerating development and commercialization efforts to meet growing domestic and international demand. “We developed our Counter-UAS system with future threats in mind, and the executive order has made it clear that the time to act is now,” said Dr. Shaun Passley, CEO of ZenaTech. “Integrating this technology into the ZenaDrone 1000 positions us to meet urgent security needs with a smart, autonomous aerial defense platform and be considered a provider of safe, trusted, and mission-ready solutions.” ZENA’s path to commercializing Counter-UAS technology could be much smoother compared to other players based on its existing relationship with the DoD. Previously, the company completed paid trials with both the US Airforce and US Naval Research using its drones for carrying critical cargo. Furthermore, ZenaTech signed Blue Unmanned Aerial Systems (UAS) and US National Defense Authorization Act (NDAA) compliant partner agreements for its supply chain to sell its ZenaDrone 1000 AI drone solutions to US Defense branches and to NATO forces. Draganfly Inc. (NASDAQ:DPRO) develops quality, cutting-edge drone solutions, software, and AI systems that revolutionize how organizations can do business. The company has emerged as one of the key beneficiaries of Trump’s executive orders following its recent selection by the Cochise County Sheriff’s Department to support a new drone pilot program aimed at enhancing surveillance and operations along the southern border. The Cochise County Sheriff’s Department is recognized nationally for its innovative use of technology in law enforcement, previously garnering commendations and visits from President Trump and Vice President JD Vance. Under this new pilot program, the department will deploy the Draganfly family of drones for extended border surveillance, quick-response missions, and nighttime operations The southern border is one of America’s most critical national security frontiers, and the department believes that the partnership with Draganfly will usher in the next phase of smart border enforcement. That partnership follows an earlier announcement of the first deliveries of Draganfly’s revolutionary Flex FPV (First Person View) systems under an order from a major U.S. military prime contractor supporting land systems operations for allied forces. Draganfly continues to experience growing demand across defense and public safety sectors as organizations seek trusted, North American-developed UAS platforms capable of adapting to the evolving realities of modern warfare. The company recently closed its previously announced $13.75 million public offering, further reaffirming investor confidence in the stock. Draganfly currently intends to use the net proceeds from the offering to fund its capabilities to meet demand for its new products, including potential acquisitions and research and development. Unusual Machines, Inc. (NYSE:UMAC), a US manufacturer of drones and NDAA-compliant components, also appears well positioned to capitalize on America’s quest to become a leader in the development, commercialization, and export of unmanned aerial systems. Earlier this month, the company announced it had signed a lease for a 17,000-square-foot drone motor production facility in Orlando, Florida, with the intention of significantly expanding the company's domestic manufacturing capabilities. This factory marks a major milestone in UMAC’s strategy to rapidly onshore drone component manufacturing and solve one of the major pain points in the American drone supply chain. The facility is designed to support the production of high-performance brushless motors for first-person view (FPV) and commercial drones. According to its design, it will eventually scale to monthly production volumes exceeding 50,000 motors. Unusual Machines is pursuing a dual-sourcing strategy for critical components such as magnets, bearings, and stators to insulate against supply chain disruptions. The company will offer both made-in-USA and globally sourced motor variants to meet different regulatory and customer needs. On June 12, the company announced it had signed a definitive agreement to acquire Rotor Lab, an Australian developer and manufacturer of electric motors and propulsion systems for unmanned aerial systems, in an all-stock deal valued at $7 million. These motors will be among the first to enter production at Unusual Machines’ new U.S.-based motor factory in Orlando, Florida, which is expected to begin operations in September. Red Cat (NASDAQ:RCAT) issued a statement in support of the executive orders from the White House seeking to advance U.S. leadership in UAS and reinforce the resilience of America’s domestic industrial base. Red Cat reiterated that it remains ready to meet this moment with its proven, electric vertical takeoff and landing systems that utilize advanced AI and computer vision solutions from partners including Palantir, Palladyne AI, Athena AI, and Primordial Labs. The company’s Black Widow drone, a small unmanned aerial system (sUAS) designed for short-range reconnaissance (SRR) missions, has already made significant inroads with the DoD. The DoD cleared Red Cat's military-grade sUAS in 2023, designating it as a Blue UAS. The system, which was selected for the U.S. Army’s SRR Program of Record contract, provides military operators with improved situational awareness, autonomous capabilities, and rugged performance in contested environments. Earlier this year, the company announced it had secured new orders totaling $518,000 for its Edge 130 drone system for the U.S. Army National Guard and another government agency. The drone is part of Red Cat's family of low-cost, portable, unmanned reconnaissance and precision lethal strike systems, and the orders further validate the performance and unique capabilities of the system. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performances are not statements of historical fact and may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by to assist in the production and distribution of this content. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only; you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third-party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Inc Mark McKelvie +1 585-301-7700 markrmckelvie@gmail.com Company Website http://razorpitch.com

June 18, 2025 08:00 AM Eastern Daylight Time

Article thumbnail News Release

HNO International Leads Groundbreaking Collaboration to Transform Toxic Fracking Water Into Clean Hydrogen for up to $5M in Annual Hydrogen Sales

HNO International

HNO International, Inc. (OTC: HNOI), a leader in clean hydrogen innovation, is proud to announce a strategic collaboration with three pioneering companies to achieve a world-first: converting toxic fracking wastewater—one of the most environmentally damaging byproducts of oil and gas production—into clean, usable hydrogen. The initiative brings together: An oil and gas operator in Texas providing the supply of toxic fracking water. Q3 Power, whose proprietary thermal technology transforms the wastewater into clean, distilled water by vaporizing and condensing it. Enapter, a German-based technology leader in modular AEM electrolyzers that convert distilled water into hydrogen using electricity. Clean H2, Enapter’s exclusive US distributor, is supporting the deployment of this advanced technology. HNO International, the architect of the collaboration, integrating the technologies into a single clean energy value chain, managing hydrogen production and dispensing infrastructure. Fracking water—used in hydraulic fracturing to extract oil—becomes irreversibly toxic due to chemical additives and subsurface contaminants. Traditionally, this wastewater is disposed of in deep injection wells, a method that is fraught with environmental risks and concerns about long-term groundwater contamination. The initial site is designed to produce up to 1,500 kg of hydrogen per day, which translates into potential annual hydrogen sales of up to $5 million. The partnership’s vision is transformative: convert one of the most toxic substances on Earth into a clean energy carrier that can help power the planet. “From pollution to power—that’s the story we’re telling,” said Don Owens, Chairman and CEO of HNO International. “We’re taking water that traditionally can’t be reused, recycled, or safely disposed of, and turning it into hydrogen, a clean, zero-emission fuel. It’s the kind of environmental turnaround the world needs more of.” The process begins with Q3 Power’s steam-based system, which isolates and condenses fracking water into distilled form, leaving behind a concentrated, potentially recoverable residue. This clean water is then passed to Enapter’s cutting-edge electrolyzers to produce high-purity green hydrogen. HNOI orchestrates the integration of these systems, managing the infrastructure and logistics necessary for full-scale hydrogen production and delivery. This landmark collaboration represents a convergence of environmental responsibility, advanced engineering, and visionary leadership—proving that even the most problematic industrial waste can become part of the clean energy solution. “Every gallon of toxic wastewater we treat is a gallon of clean hydrogen potential,” Owens added. “This partnership exemplifies the circular economy in action and sets the stage for global replication.” About HNO International, Inc. HNO International (OTC: HNOI) is a clean energy technology company advancing the future of hydrogen through scalable, off-grid energy solutions. With industry-defining products like the Scalable Hydrogen Energy Platform (SHEP™), Compact Hydrogen Refueling Station (CHRS™), the Mobile Hydrogen Refueling System (MHRS), and the newly launched HyGrid™ system — all designed to accelerate the global shift to sustainable energy. About Q3 Power At Q3 Power, the driving force is a singular, transformative mission: to revolutionize the way our world generates and consumes energy, making sustainable power accessible to all. With environmental challenges looming and the need for clean energy solutions becoming increasingly urgent, we are committed to addressing this pressing issue head-on. Their groundbreaking technology delivers exponential power production on an unprecedented scale, producing 10 megawatts in less than one acre. This makes Q3 Power the most efficient and sustainable power solution on Earth. About Enapter Electrolyzers Enapter is the market leader in AEM electrolyzers–innovative devices that produce green hydrogen. The company’s patented and proven anion exchange membrane (AEM) technology eliminates the need for expensive and rare raw materials such as iridium and enables maximum yield from fluctuating renewable energies such as solar and wind through a unique modular design, resulting in highly efficient production of green hydrogen. Thousands of Enapter AEM electrolyzers are already in use at around 360 customers in more than 55 countries in the fields of energy storage, industrial applications, refueling, power-to-X and research. The Enapter Group is headquartered in Germany and has a research and production site in Italy. Enapter AG (H2O) is listed on the regulated market of the Frankfurt and Hamburg stock exchanges, ISIN: DE000A255G02. HNO International (OTC: HNOI) is a clean energy technology company advancing the future of hydrogen through scalable, off-grid energy solutions. With industry-defining products like the Scalable Hydrogen Energy Platform (SHEP™), Compact Hydrogen Refueling Station (CHRS™), the Mobile Hydrogen Refueling System (MHRS), and the newly launched HyGrid™ system — all designed to accelerate the global shift to sustainable energy. This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov. Contact Details Donald Owens +1 951-290-9006 dowens@hnointl.com Company Website https://hnointl.com/

June 18, 2025 08:00 AM Eastern Daylight Time

Article thumbnail News Release

American Battery Materials Announces Expansion of Strategic Focus to Include Magnesium Recovery at Utah’s Paradox Basin

American Battery Materials Inc

American Battery Materials, Inc. (OTC PINK: BLTH) ("ABM"), a U.S.-based company dedicated to advancing critical mineral resource development, today announced that it is expanding its strategic extraction efforts beyond lithium to include magnesium recovery at its flagship project in Utah’s Paradox Basin. The Paradox Basin resource—already recognized for its lithium concentrations—also contains high levels of Magnesium. ABM’s mineral rights cover 743 claims across 14,260 acres, offering a unique opportunity to co-extract lithium and magnesium using advanced Direct Lithium Extraction (DLE) techniques. “Expanding our efforts to recover magnesium is a natural progression of our mission to support the U.S. energy transition,” said David E. Graber, CEO of American Battery Materials. “With demand for lightweight metals growing across the defense, aerospace, and automotive industries, developing a domestic magnesium supply chain is vital for national competitiveness and sustainability.” Magnesium, recently identified as a critical material by the U.S. Department of Energy and the Department of Defense, is essential in a variety of high-growth sectors, including electric vehicles, electronics, biodegradable medical implants, and lightweight structural components. ABM’s DLE-based approach is designed to efficiently recover both lithium and magnesium with minimal environmental impact. The company’s closed-loop extraction system returns the majority of extracted brine to its source, significantly reducing land usage and eliminating the need for open-pit mining or evaporation ponds. About American Battery Materials, Inc. American Battery Materials, Inc., headquartered in Greenwich, Connecticut, is a U.S.-based company focused on the exploration, acquisition, and development of lithium and other battery materials critical to the global energy transition. ABM is committed to sustainable practices and delivering value to its stakeholders through strategic partnerships and innovative projects. For Media Inquiries: American Battery Materials, Inc. 500 West Putnam Avenue, Suite 400 Greenwich, CT 06830 +1 800-998-7962 ir@americanbatterymaterials.com To the extent that statements contained in this press release are not descriptions of historical facts regarding the Company, they are forward-looking statements reflecting the current beliefs and expectations of management. Words such as "believe," "goal," "plan," "feel," "may," "will," "expect," "anticipate," "estimate," "intend," "target" and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause our future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of the Company, please see the Company's Annual Report on Form 10-K for the year ended December 31, 2024 and its Quarterly Reports on Form 10-Q, including but not limited to the discussion under "Risk Factors" therein, which the Company has filed with the SEC and may be viewed at http://www.sec.gov. Contact Details Investor Relations +1 800-998-7962 ir@americanbatterymaterials.com Company Website https://www.americanbatterymaterials.com/

June 18, 2025 07:00 AM Eastern Daylight Time

Article thumbnail News Release

CURE ALZHEIMER’S FUND PRESENTS THE JEFFREY L. MORBY PRIZE FOR EXCEPTIONAL RESEARCH

Alzheimer’s Disease Research Foundation

Cure Alzheimer’s Fund, a nonprofit dedicated to funding the most promising research to prevent, slow or reverse Alzheimer’s disease (AD), has announced the recipients of the second annual Jeffrey L. Morby Prize. Senior author Andrew S. Yoo, Ph.D., and first author Zhao Sun, Ph.D., both of Washington University School of Medicine in St. Louis, were selected by their peers for their paper “ Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming,” published in Science in August 2024. The Morby Prize is named in honor of the late Co-Founder of Cure Alzheimer’s Fund, Jeffrey L. Morby, who inspired the nonprofit’s mission 20 years ago to fund research as a path to ending Alzheimer’s disease. Mr. Morby passed away in September 2023. Established in 2024, the Morby Prize will be awarded annually to the senior and first authors of a recent scientific publication that transforms the fundamental understanding of Alzheimer’s disease and opens new paths to translate scientific results into effective ways to prevent, diagnose or treat the disease. This year’s award included $200,000 for the senior author’s lab for Alzheimer’s disease-related research. “Honoring researchers whose work is determined by their peers as breakthrough thinking and having meaningful impact on the Alzheimer’s community is a fitting tribute to Jeff’s remarkable legacy of empowering scientists to pursue rigorous and innovative research,” said Meg Smith, CEO of Cure Alzheimer’s Fund. “The many extraordinary CureAlz-funded projects that resulted in published papers in 2023 and 2024 made the competition for this award fierce, and the endorsement of this paper by their peers speaks to the importance of the work of Drs. Yoo and Sun and their co-authors.” The paper describes a groundbreaking method to study aged neurons in the lab without requiring a brain biopsy, enabling more accurate modeling of late-onset Alzheimer’s disease. By transforming skin cells from patients directly into neurons that reflect the aging process, scientists now can observe key disease features, such as amyloid beta plaque buildup, offering new insights into Alzheimer’s disease development and potential treatment approaches. “With the demonstration that direct neuronal reprogramming can model neuropathological features of late-onset Alzheimer’s disease, this method will enable us to dissect how aging, as the primary risk factor, contributes to neurodegeneration,” said Dr. Yoo. “Moreover, the generous support from the Jeffrey L. Morby Prize will further allow us to develop reprogramming approaches to generate different neuronal subtypes and investigate neuron-intrinsic aging mechanisms in the context of specific cell types. We are excited about the possibility of delineating the mechanisms by which different neuronal subtypes become vulnerable or resilient to AD with aging.” About The Yoo Lab Andrew S. Yoo, Ph.D., is a distinguished neuroscientist and professor in the Department of Developmental Biology at Washington University School of Medicine in St. Louis. His lab focuses on microRNAs as neurogenic genetic inputs and reprogramming effectors to generate human neurons by directly reprogramming non-neural somatic cells. Using this approach, his team investigates how aging in human neurons contributes to the adult- and late-onset of neurodegeneration employing neurons derived from individuals with various neurodegenerative disorders. About Cure Alzheimer's Fund Cure Alzheimer’s Fund is a nonprofit dedicated to funding the most promising research to prevent, slow or reverse Alzheimer’s disease. Since its founding in 2004, Cure Alzheimer’s Fund has provided 971 grants to more than 300 of the world’s leading researchers and contributed more than $232 million to research. Its funded initiatives have been responsible for many key breakthroughs in understanding the causes and pathology of Alzheimer’s disease. Cure Alzheimer’s Fund has achieved a 100% perfect score and a Four-Star rating for 13 consecutive years from Charity Navigator. Cure Alzheimer’s Fund also received a Platinum Seal of Transparency from Candid, formerly known as GuideStar. Our Board of Directors, Trustees and a core group of other donors direct their donations to our overhead expenses so that 100% of general donations go to our research program. For more information, visit CureAlz.org. Contact Details Barbara Chambers +1 978-417-9890 bchambers@curealz.org Company Website http://curealz.org

June 18, 2025 05:25 AM Eastern Daylight Time

Article thumbnail News Release

Kevel Powers Kleinanzeigen's Next-Generation Retail Media Network

Kevel

Kevel, the industry leader in API-based ad serving technology, today announced that Kleinanzeigen, Germany's largest online classifieds platform, has chosen Kevel's Retail Media Cloud® to power its next-generation retail media network. This partnership marks a significant milestone in Kleinanzeigen's digital advertising strategy and underscores Kevel's expanding presence in the European market. By leveraging Kevel's cutting-edge technology, Kleinanzeigen aims to create a sophisticated, custom-built advertising platform that aligns with its commitment to connecting local buyers, marketplace sellers & brands. The new retail media network will enable Kleinanzeigen to offer its advertising partners more targeted and effective ways to enhance the user-experience and reach high-intent consumers with more than 700M monthly visits. Working closely with the Kevel team, Kleinanzeigen will utilize the Retail Media Cloud® to seamlessly integrate retail media offerings into its advertising strategy. This collaboration will focus on enhancing the user experience across both owned and off-site channels through personalization and innovative ad formats, leveraging Kleinanzeigen's unique first-party data. James Avery, Founder and CEO of Kevel, commented, "We are excited to welcome Kleinanzeigen to the Kevel family. Their decision to build their retail media network on our Retail Media Cloud® platform demonstrates the versatility and strength of our API-first approach. We look forward to helping Kleinanzeigen create a truly unique advertising experience that reflects their brand values and meets the evolving needs of both advertisers and users." Key benefits of the Kleinanzeigen-Kevel partnership include: Enhanced Scalability: Working with Kevel means Kleinanzeigen can now enhance their capabilities and build for scale to ensure they are efficiently and effectively working toward their goal of scaling its customer-base and ad inventory across their media network. Diverse Ad Formats: Kevel's platform supports a wide range of ad units, allowing Kleinanzeigen to implement native ads, sponsored listings, and other custom formats seamlessly. Rapid Deployment: With Kevel's technology, Kleinanzeigen can launch custom retail media campaigns in as little as 14 days, ensuring agility and responsiveness to market demands. Data Compliance and Security: Kevel's industry-leading data compliance features allow Kleinanzeigen to confidently use its user data while maintaining strict privacy standards. Improved Advertiser ROI: More precise targeting and diverse ad formats are expected to significantly enhance returns for Kleinanzeigen's advertising partners. Fabian Schmitt-Pfeifer, Head of Product Retail Media at Kleinanzeigen, said, "At Kleinanzeigen, we're constantly seeking innovative ways to improve our users' experience and provide value to our advertising partners. Kevel gives us the tools and flexibility we need to build a retail media network that's uniquely tailored to our platform. We're excited about the possibilities this opens up for our business, our users, and our advertising partners." The implementation of Kevel's Retail Media Cloud® began earlier this year with the first ad placements going live in April and is expected to be completed in phases over the coming months. About Kevel Kevel is revolutionizing retail media with its AI-powered, API-first Retail Media Cloud®, empowering retailers, marketplaces, and eCommerce platforms to build, level up, and scale custom ad networks while maintaining full control of their first-party data. By offering unparalleled flexibility in ad serving, audience segmentation, and self-serve capabilities, Kevel enables businesses to launch impactful retail media programs in weeks, not years. Kevel's mission is rooted in the belief that every digital retailer should have the tools to create their own tailored ad platform, comparable to industry leaders like Amazon. Harnessing the power of AI for data-driven decision-making, Kevel has helped leading brands such as Chewy, The Home Depot, Dollar General, John Lewis, Sonae, Lyft, El Corte Ingles, Slickdeals, and others launch impactful retail media networks—fostering innovation and unlocking new revenue opportunities. With Kevel, businesses can differentiate their ad programs, maximize their share of media dollars, and take control of their retail media destiny. Discover the power of customization and performance at www.kevel.com. About Kleinanzeigen Kleinanzeigen is the leading online classifieds platform in Germany. On average, more than 55 million ads are posted in a wide range of categories – from children's needs to electronics and real estate. Most of the items listed are second-hand. In this way, users make an active contribution to greater sustainability. Kleinanzeigen also offers companies the opportunity to present their services online in a simple way. Kleinanzeigen was launched in September 2009 as eBay Kleinanzeigen. In May 2023, the company was renamed Kleinanzeigen. Contact Details Kevel Jennifer Choo Director of Marketing +1 973-343-8819 jchoo@kevel.com

June 17, 2025 09:00 AM Eastern Daylight Time

Article thumbnail News Release

Mariner Expands Independent Platform Leadership Team Amid Surge in Advisor Demand

Mariner

Mariner, a national financial services firm, is reaffirming its strategic commitment to the independent advisor channel with the continued expansion of Mariner Independent, the firm’s supported independence platform. Serving more than 1,100 advisors and overseeing approximately $40 billion in assets under management (AUM) and assets under advisement (AUA), Mariner Independent is a core driver of the firm’s growth strategy. As demand accelerates flexible affiliation models and long-term monetization pathways, the firm is enhancing its leadership team to support the next phase of platform evolution. In doing so, Mariner has named Rob Sandrew as Head of Mariner Independent to guide the platform’s ongoing innovation, advisor experience, and expansion into new partnership models. Sandrew brings a unique blend of operational and strategic leadership; prior to joining Mariner, he served as chief growth officer at Integrated Partners, where he helped grow the firm from $3 billion to over $21 billion in assets. In addition to Sandrew, Verne Marble recently joined Mariner Independent as Managing Director. Marble brings a wealth of experience in distribution and leadership, having held senior positions at Private Advisor Group, LPL Financial, and Edelman Financial Engines. “This is a pivotal time for independent advisors, and I’m proud to be stepping into a leadership role at Mariner Independent as it enters its next stage of growth,” said Sandrew. “We have a real opportunity and the capabilities to deepen the support and flexibility advisors are looking for, and I’m eager to help shape a platform that truly aligns with where both the industry and advisor expectations are heading.” These leadership appointments come during a period of robust growth for Mariner as the firm expands its independent offerings, including appealing buyout options for affiliated 1099 advisors seeking succession solutions. Recent transactions, such as the acquisition of Ocean Heights Advisors, provide advisors with an opportunity to monetize their practice while transitioning into a comprehensive W-2 structure that includes bespoke terms, upfront cash, and equity, along with a three-year earnout based on operating margins. “We’ve seen tremendous growth from our independent advisors, and it’s a clear signal that the model is working. Advisors want the freedom to run their business their way, with the support to scale and the options to monetize when the time is right,” said Marty Bicknell, CEO and president of Mariner. “That’s exactly what Mariner Independent is built to deliver. With Rob and Verne stepping in, we’re expanding that vision and setting the pace for what’s next in the independent space. Their leadership ensures Mariner Independent will continue to be a destination for growth-minded professionals who want to remain independent without feeling alone.” Since its launch in 2020, Mariner’s supported independence model has delivered a robust suite of services including back-office support, practice management, marketing, investment solutions, and compliance resources, all backed by a dedicated team of over 300 professionals. Sandrew and Marble will both join the Mariner Independent Executive Committee, partnering with the firm’s leadership to shape the future direction of this dynamic platform. About Mariner Mariner is a privately held national financial services firm equipped with the experience to meet your modern wealth needs. Our advisors have access to in-house expertise covering everything from tax, estate, trust, and insurance to investment banking and valuation, so they can maximize time spent creating unified wealth plans with clients. By opening more windows of wealth, we can create opportunities to positively impact the lives of many. With this purpose, we intend to raise the bar for the entire industry. Founded in 2006 with $300 million in assets under advisement, Mariner and its affiliates now advise on nearly $555 billion in assets which includes assets under advisement and assets under management as of 3/31/25. Learn more at www.mariner.com Contact Details Hot Paper Lantern Remi Yuter mariner@hotpaperlantern.com Company Website https://www.mariner.com/

June 17, 2025 09:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

GET OSHA Courses Now Offering Authorized OSHA 30 Certification Across the US

Rev Up Marketers

As workplace safety regulations tighten and demand for certified professionals surges, Get OSHA Courses is stepping up with an innovative, user-friendly platform offering OSHA 30 online and other OSHA training online, transforming how American workers and companies approach safety. With a mission to simplify access to OSHA certification online, Get OSHA Courses delivers fast, 100% online OSHA 30-Hour Training that meets OSHA guidelines, fits into busy schedules, and doesn’t break the bank. From construction workers to warehouse staff and safety officers, the platform is designed for everyone looking to advance their safety knowledge and meet legal compliance requirements, anytime, anywhere. A Smarter Way to Get OSHA 30 Certified OSHA 30 is an essential certification for workers and supervisors of high-hazard professions. This incorporates construction, general industry as well as warehousing. It’s part of the 30-hour OSHA Outreach Training Program. In many states, it’s required by law for various jobs. It’s often a must for job eligibility, too. Get OSHA Courses stands out in a crowded market by offering: Excellent OSHA 30 Online training course material. Instant access with self-paced modules. Mobile-friendly platform for on-the-go learning. Printable OSHA Safety Certification upon completion. Official OSHA DOL Plastic Card. Round-the-clock customer support. Group discounts for businesses & bulk training orders This efficient process helps workers finish their OSHA 30 Certification quickly. Companies can train teams without interrupting their operations. Meeting a Growing Need Across the U.S As industries grow after COVID, safety remains a top concern. The U.S. Department of Labor is doing a lot to sensitize people on the dangers at work. Due to the increased pressure, the demand of quality OSHA 30-Hour Training programs has increased tremendously. In response, we scaled rapidly to meet nationwide needs, helping thousands of professionals get certified and stay legally compliant, from New York City skyscraper crews to manufacturing hubs in Texas and beyond. Trusted by Workers. Respected by Employers. Backed by industry-recognized partners and aligned with OSHA guidelines, we ensure that certifications should be legitimate and also respected by employers across all 50 states. Whether it's for individuals looking to advance their careers or businesses seeking to quickly certify their teams, the platform's flexibility and compliance-first approach make it a reliable partner. An Invitation to Train Smarter, Not Harder With an ever-evolving regulatory landscape, OSHA 30 training online is not only mandatory; it's essential. We are not just offering another online class; it’s providing a reliable, affordable pathway to workplace safety, job advancement, and peace of mind. Those seeking OSHA 30 Online or other OSHA safety certification options can sign up today and begin training immediately. Businesses interested in group enrollments can contact the team directly for custom solutions. About Get OSHA Courses Get OSHA Courses is an online safety training platform dedicated to delivering fast, affordable, and accessible OSHA certification online. With a focus on OSHA 30-Hour Training, the company serves thousands of workers and businesses nationwide, helping them stay compliant, job-ready, and safe on the job. Contact Details Get OSHA Courses Shawn Malik +1 218-503-5891 support@getoshacourses.com Company Website https://getoshacourses.com

June 17, 2025 07:45 AM Eastern Daylight Time

Article thumbnail News Release

Deckart Launches Striking New Collection of Skateboard Art Decks

Rev Up Marketers

Melbourne-based design studio DeckArt has just released a fresh collection of limited-edition skateboard art decks, offering a bold new take on the intersection of skate culture and contemporary design. The 2025 lineup features original graphics created in collaboration with a handpicked group of visual artists, illustrators, and designers. Each deck is printed on Canadian maple and produced in small batches, continuing DeckArt’s focus on quality, creativity, and collectability. The new drop brings together a range of styles — from bold and expressive to minimalist and refined — all aimed at reimagining the skateboard as a meaningful design object. “This drop is about exploring new visual ideas while staying true to the roots of skate culture,” said Sam West, founder of DeckArt. “Each piece is a collaboration — not just between us and the artists, but with the wider culture and community around it. Whether you ride it or hang it, it’s meant to spark something.” Available now exclusively at www.deckart.com.au, this new release has already started gaining attention from collectors, stylists, and design-forward retailers looking for pieces that reflect identity, creativity, and edge. About DeckArt DeckArt is an independent Australian design studio turning skateboard decks into limited-edition art. Founded in 2023 by creative director Sam West, the studio works with artists across disciplines to produce small-batch collections that celebrate individuality, subculture, and design. Each DeckArt release is crafted to be both visually striking and culturally grounded — whether displayed on a wall or rolling through the street. Contact Details Deckart Sam West contact@deckart.com.au Company Website https://deckart.com.au/

June 17, 2025 07:24 AM Eastern Daylight Time

Image
Article thumbnail News Release

BiomX Stock Could Soar 3000% As This $10M Biotech Cracks The 'Superbug' Code, Wall Street Says

Global Markets News

BiomX Inc. (NYSE: PHGE)* has achieved what Big Pharma couldn't accomplish in over 20 years — successful clinical trials using viruses to treat life-threatening infections that no longer respond to antibiotics. The $10 million biotech has reported positive Phase 2 results in diabetic foot bone infections, a condition so challenging that no new drugs have been approved for it in two decades. Meanwhile, their cystic fibrosis program showed 14% of patients completely cleared chronic lung infections after just 10 days of treatment. Approximately 160,000 lower limb amputations occur annually in diabetic patients in the U.S., with 85% caused by diabetic foot infections or diabetic foot osteomyelitis — creating an $8 billion annual healthcare burden according to company data. Current treatments rely on antibiotics that increasingly fail due to resistance, often leaving amputation as the only option. Clinical Breakthroughs Across Two Major Programs BiomX's March 2025 Phase 2 results in diabetic foot osteomyelitis from 41 patients delivered notable outcomes. The company achieved statistically significant percent area reduction of ulcer size, with p-values of 0.046 at week 12 and 0.052 at week 13. The treatment showed separation from placebo starting at week 7, with differences greater than 40% by week 10. BiomX also demonstrated statistically significant improvements in ulcer depth and reducing ulcer area expansion, while BX211 was safe and well-tolerated throughout the study. The company's cystic fibrosis program has been equally impressive. In their Phase 1b/2a study, 14.3% of patients converted to sputum culture negative for P. aeruginosa after 10 days of treatment, compared to 0% in the placebo group. One patient had been infected for 35 years before achieving complete clearance. The FDA has granted this program both Fast Track designation and Orphan Drug Designation, potentially accelerating the approval pathway. BiomX's approach uses bacteriophages — viruses that naturally target and kill specific bacteria — instead of traditional antibiotics that bacteria can develop resistance against. The company has overseen more than 50 compassionate use cases with no significant side effects to date. Military Validation and Wall Street's Bullish Take The U.S. Defense Health Agency has provided $40 million in non-dilutive funding to BiomX's diabetic foot program, representing significant validation of the technology. "They're seeing soldiers coming out of the Ukraine war with extremely antibiotic-resistant infections," CEO Jonathan Solomon said during the company's May 2025 earnings call. Despite the clinical progress and military backing, BiomX trades at approximately $10 million market cap — a disconnect0 that has caught Wall Street's attention. H.C. Wainwright maintains a Buy rating with a $15 price target, representing potential upside of over 3000% from recent levels around $0.4 Laidlaw & Company rates the stock Buy with a $16 price target, suggesting almost 4000% upside potential. Laidlaw analyst Yale Jen called the recent data "an absolutely positive surprise" and characterized BX211 as "a high value and clinically de-risked asset." The analysts' optimism stems from the clinical validation across both programs, massive addressable markets, and limited competition in the phage therapy space. Major Catalysts on the Horizon BiomX estimates addressable markets exceeding $2.5 billion globally for their diabetic foot program and $1.6 billion for cystic fibrosis based on patient populations and potential pricing benchmarks. The company expects to have sufficient funding through Q1 2026, aligning with anticipated BX004 Phase 2b results in cystic fibrosis. Key upcoming catalysts include the Phase 2b readout for their cystic fibrosis program expected in Q1 2026, ongoing Phase 2/3 trial discussions with the FDA for their diabetic foot program, and potential regulatory meetings in the second half of 2025. The company is also exploring partnership opportunities as the phage therapy space attracts increasing attention from large pharmaceutical companies. With validated clinical data, military funding, and Wall Street price targets suggesting potential returns exceeding 3000%, BiomX could offer investors exposure to phage therapy as a potential new approach to treating antibiotic-resistant infections. As the global antibiotic resistance crisis intensifies, the company's nature-based approach to killing bacteria positions it at an interesting inflection point in infectious disease treatment. BiomX shares were trading at ~$0.4 at last check Recent News Highlights from BiomX BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates BiomX Announces Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO) * Legal Disclaimer & Disclosure: Nothing in this report constitutes financial or investment advice, nor does it represent an offer to buy or sell securities. This report is published by Wall Street Wire™. The operators of Wall Street Wire, arx advisory, are not registered brokers, dealers, or investment advisers. This report contains and is a form of paid promotional content or advertisement for BiomX Inc and was produced as part of their paid subscription to Wall Street Wire. This report has not been reviewed or approved by BiomX Inc prior to publication. The operators of wall street wire have received or are expected to receive a monthly recurring fee of five thousand united states dollars via wire transfer from BiomX as part of an ongoing agreement starting June 1st, 2025 in return for social media distribution and promotional coverage services, and receive additional compensation for non promotional unrelated data and advisory services on top of that. They do not hold any shares in BiomX. Please review the full disclaimers and compensation disclosures here for further details: redditwire.com/terms. We are not responsible for the price targets mentioned in this article nor do we endorse them, they are quoted based on publicly available news reports believed to be reliable and additional or price targets may exist that may not have been quoted. Readers are advised to refer to the full reports mentioned on various systems and the disclaimers/disclosures they may be subject to. Contact Details News Coverage ronald@futuremarketsresearch.com

June 16, 2025 07:04 PM Eastern Daylight Time

1 ... 56789 ... 3895